Irach Taraporewala

Company: EOM Pharmaceuticals

Job title: Chief Executive Officer

Seminars:

Addressing Treatment Resistance & Improving Outcomes in Retinal Vein Occlusion with a Novel Multimodal Eye Drop Therapy 11:00 am

Overview of the E147 eye drop, a second-generation product targeting retinal vein occlusions with a unique mechanism of action Highlight the positive results from the pilot study and plans for upcoming US trials in retinal vein occlusion and diabetic retinopathy Discuss how the E147 eye drop’s ability to target multiple growth factors involved in vascular…Read more

day: Day One

Panel Discussion: How Can We Practically Implement New Treatments for Retinal Vascular Disorders, Streamlining Clinical Trials to Set Yourself Up for Success? 12:00 pm

How can you streamline trial design, incorporating new drug and technology advancements, to ensure a smoother transition through clinical phases for retinal therapies? What are the best strategies for forming partnerships and collaborations to support clinical development and commercialization efforts? How can patient engagement and feedback be integrated into the development process to enhance the…Read more

day: Day One